Company Overview of Avidia, Inc.
Avidia, Inc. is a biopharmaceutical company that discovers and develops therapeutic proteins. The company offers Avimer therapeutic proteins, which are used to address various therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Avidia, Inc. was formerly known as Avidia Research Institute, Inc. Avidia, Inc. was founded in 2003 and is based in Mountain View, California.
2450 Bayshore Parkway
Mountain View, CA 94043
Founded in 2003
Key Executives for Avidia, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Avidia, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.